ContraFect Corporation Confirms Appointment of Julia P. Gregory as CEO and Director, and Appoints David N. Low, Michael J. Otto and Roger J. Pomerantz to Board of Directors YONKERS, NY--(Marketwired - Apr 24, 2014) - ContraFect Corporation, a leader in the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant...

ContraFect Announces Management Team Changes YONKERS, NY--(Marketwired - Nov 21, 2013) -  ContraFect Corporation announced that Ms. Julia P. Gregory was appointed interim Chief Executive Officer, succeeding Dr. Robert Nowinski, the...

ContraFect Names Sol Barer Chairman of the Board YONKERS, NY--(Marketwire - Mar 8, 2012) - ContraFect Corporation announced today that Sol Barer, Ph.D. has been named the company's Chairman of the Board. Dr. Barer has been a director of...